2seventy bio, Inc.
(NASDAQ GS: TSVT)
Rigrodsky Law, P.A. is investigating 2seventy bio, Inc. (“2seventy”) regarding possible breaches of fiduciary duties and other violations of law related to 2seventy’s agreement to be acquired by Bristol Myers Squibb. Under the terms of the agreement, 2seventy shareholders will receive $5.00 per share in cash.